SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-000921
Filing Date
2021-01-05
Accepted
2021-01-05 16:10:30
Documents
16
Period of Report
2021-01-04
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm211620d1_8k.htm   iXBRL 8-K 31825
2 EXHIBIT 3.1 tm211620d1_ex3-1.htm EX-3.1 6060
3 EXHIBIT 3.2 tm211620d1_ex3-2.htm EX-3.2 114909
4 EXHIBIT 99.1 tm211620d1_ex99-1.htm EX-99.1 25095
8 GRAPHIC tm211620d1_ex99-1img01.jpg GRAPHIC 16895
  Complete submission text file 0001104659-21-000921.txt   414840

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nvus-20210104.xsd EX-101.SCH 3214
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvus-20210104_lab.xml EX-101.LAB 35274
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvus-20210104_pre.xml EX-101.PRE 23165
9 EXTRACTED XBRL INSTANCE DOCUMENT tm211620d1_8k_htm.xml XML 3888
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 21505527
SIC: 2834 Pharmaceutical Preparations